Shared on 05 Nov 25
Fair value Decreased 0.78%Analysts have lowered their price target for Prestige Consumer Healthcare slightly, from $80.80 to $80.17. They cite a modest reduction in projected revenue growth, even though profitability metrics remain stable.
Shared on 21 Oct 25
Fair value Decreased 2.42%Analysts Trim Prestige Consumer Healthcare Price Target Amid Guidance Cut and Buyback Activity
Analysts have slightly reduced their price target for Prestige Consumer Healthcare from $82.80 to $80.80. This change is due to marginal adjustments to projected valuation metrics and profit assumptions.
Shared on 11 Aug 25
Fair value Decreased 6.97%Pillar5 Acquisition And Ecommerce Momentum Will Foster Enduring Supply Reliability
The consensus Analyst Price Target for Prestige Consumer Healthcare was lowered to $82.80, primarily reflecting reduced revenue growth expectations and a slight contraction in net profit margin. What's in the News Prestige Consumer Healthcare is actively seeking M&A opportunities, leveraging strong free cash flow and reduced leverage.
Shared on 08 May 25
Fair value Increased 0.56%Hydralyte's International Expansion Will Drive Future Success
Shared on 30 Apr 25
Fair value Increased 0.99%Hydralyte's International Expansion Will Drive Future Success
Shared on 23 Apr 25
Hydralyte's International Expansion Will Drive Future Success
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Hydralyte's International Expansion Will Drive Future Success
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Decreased 2.77%Hydralyte's International Expansion Will Drive Future Success
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 1.99%Hydralyte's International Expansion Will Drive Future Success
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Hydralyte's International Expansion Will Drive Future Success
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Hydralyte's International Expansion Will Drive Future Success
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 11 Mar 25
Fair value Decreased 0.15%Hydralyte's International Expansion Will Drive Future Success
AnalystConsensusTarget made no meaningful changes to valuation assumptions.